FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Amvuttra (vutrisiran) - June 13, 2022
- Priorix (measles, mumps, and rubella virus vaccine, live) - June 03, 2022
- Fylnetra (pegfilgrastim-pbbk) - May 26, 2022
- Tyvaso DPI (treprostinil) - May 23, 2022
- Vtama (tapinarof) - May 23, 2022
- Mounjaro (tirzepatide) - May 13, 2022
- Radicava ORS (edaravone) - May 12, 2022
- Voquezna Dual Pak (amoxicillin and vonoprazan) - May 03, 2022
- Voquezna Triple Pak (amoxicillin, clarithromycin, and vonoprazan) - May 03, 2022
- Camzyos (mavacamten) - April 28, 2022
- Cuvrior (trientine tetrahydrochloride) - April 28, 2022
- Vivjoa (oteseconazole) - April 26, 2022
- Epsolay (benzoyl peroxide) - April 22, 2022
- Alymsys (bevacizumab-maly) - April 13, 2022
- Igalmi (dexmedetomidine) - April 05, 2022
- Vijoice (alpelisib) - April 05, 2022
- Tlando (testosterone) - March 28, 2022
- Locametz (gallium Ga 68 gozetotide) - March 23, 2022
- Pluvicto (lutetium lu 177 vipivotide tetraxetan) - March 23, 2022
- Hyftor (sirolimus) - March 22, 2022